CEO sold ~$1.77M of Gilead Sciences
Scheduled in advanceLoading…
Traded Sep 10, 2026 · Filed Sep 11, 2026
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
option exercise
Code M — exercise or conversion of a derivative security
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
CEO sold ~$1.77M of Gilead Sciences
Scheduled in advanceCEO sold ~$446K of Gilead Sciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.